These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6752181)

  • 21. Increase in tumor necrosis factor-alpha mRNA but not perforin mRNA expression in response to two newly characterized anti-LFA-1 monoclonal antibodies.
    Hommel-Berrey G; Bochan M; Brahmi Z
    Nat Immun; 1994; 13(6):301-14. PubMed ID: 7894201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the assessment and titration of antilymphocytic sera "in vitro" and "in vivo".
    Momchilov B; Gencheva G
    Dev Biol Stand; 1974; 27():229-32. PubMed ID: 4618535
    [No Abstract]   [Full Text] [Related]  

  • 23. Expression of T cell differentiation antigens and Ia on rat cytotoxic T lymphocytes.
    Duarte AJ; Carpenter CB; Strom TB
    J Immunol; 1982 Feb; 128(2):580-4. PubMed ID: 6976382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Methods of isolating immune cells--critical assessment, artifacts].
    Eckert R; Jenssen HL
    Allerg Immunol (Leipz); 1982; 28(3):155-64. PubMed ID: 6216793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal anti-human T-lymphocyte antibodies: enumeration and characterization of T-cell subsets.
    Van Wauwe J; Goossens J
    Immunology; 1981 Jan; 42(1):157-64. PubMed ID: 6970173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro.
    Batova A; Kamps A; Gillies SD; Reisfeld RA; Yu AL
    Clin Cancer Res; 1999 Dec; 5(12):4259-63. PubMed ID: 10632368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A monoclonal antibody (TA-1) reactive with human T lymphocytes and monocytes.
    LeBien TW; Kersey JH
    J Immunol; 1980 Nov; 125(5):2208-14. PubMed ID: 6968776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functionally different T lymphocyte subpopulations determined by their sensitivity to complement-dependent cell lysis with the monoclonal antibody 4A.
    Morishima Y; Kobayashi M; Yang SY; Collins NH; Hoffmann MK; Dupont B
    J Immunol; 1982 Sep; 129(3):1091-8. PubMed ID: 6980917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of surface antigens on highly purified human NK cells by flow cytometry with monoclonal antibodies.
    Ortaldo JR; Sharrow SO; Timonen T; Herberman RB
    J Immunol; 1981 Dec; 127(6):2401-9. PubMed ID: 6975321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased cytolytic effect of immune lymphocytes in a syngeneic tumour system following simple purification procedures.
    Vasudevan DM; Brunner KT; Cerottini JC
    Br J Cancer Suppl; 1973 Aug; 1():35-6. PubMed ID: 4804289
    [No Abstract]   [Full Text] [Related]  

  • 31. Analysis of lymphocyte sub-populations in cytocentrifuge preparations.
    Gregory CD; Shah LP; Lee H; Golding PR
    Med Lab Sci; 1986 Jan; 43(1):59-63. PubMed ID: 3515106
    [No Abstract]   [Full Text] [Related]  

  • 32. Cross-reaction of a rat-anti-mouse phagocyte-specific monoclonal antibody (anti-Mac-1) with human monocytes and natural killer cells.
    Ault KA; Springer TA
    J Immunol; 1981 Jan; 126(1):359-64. PubMed ID: 7451976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cells armed with anti-CD3 x anti-CD20 bispecific antibody enhance killing of CD20+ malignant B cells and bypass complement-mediated rituximab resistance in vitro.
    Gall JM; Davol PA; Grabert RC; Deaver M; Lum LG
    Exp Hematol; 2005 Apr; 33(4):452-9. PubMed ID: 15781336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Normal and malignant human myelocytic and monocytic cells identified by monoclonal antibodies.
    Bernstein ID; Andrews RG; Cohen SF; McMaster BE
    J Immunol; 1982 Feb; 128(2):876-81. PubMed ID: 6948042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Down-regulation of L-selectin surface expression by various leukocyte isolation procedures.
    Stibenz D; Bührer C
    Scand J Immunol; 1994 Jan; 39(1):59-63. PubMed ID: 7507260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxicity of B72.3XOKT3 bispecific antibody recognizing human colon cancer.
    Shpitz B; Stern H; Sandhu JS; Reilley RM; Tropak MB; Jansz G; Xu J; Gallinger S
    J Surg Res; 1996 Feb; 61(1):134-8. PubMed ID: 8769955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of autologous rosette-forming cells with a series of monoclonal antibodies.
    Munker R; Stünkel K; Thierfelder S
    Biomed Pharmacother; 1982; 36(4):210-2. PubMed ID: 6762229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transplant monitoring with monoclonal antibodies to human T cell subsets by 51Cr release in complement-dependent cytotoxicity (CDC-Cr): a preliminary study.
    Kovithavongs T; Dossetor JB
    Transplant Proc; 1984 Aug; 16(4):1093-6. PubMed ID: 6380056
    [No Abstract]   [Full Text] [Related]  

  • 39. GD3 ganglioside antibody augments tumoricidal capacity of canine blood mononuclear cells by induction of interleukin 12.
    Helfand SC; Dickerson EB; Munson KL; Padilla ML
    Cancer Res; 1999 Jul; 59(13):3119-27. PubMed ID: 10397254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Defining the notion of monoclonal antibodies without analysis of the production methods. Discussion of the value of these antibodies in the study and identification of lymphoid populations during rejection phenomena related to tissue transplantation].
    Faure G
    Arch Anat Cytol Pathol; 1985; 33(2):107-11. PubMed ID: 3890774
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.